LONIGUTAMAB UGODOTIN

UNII:	VJ9X8A8CJ5
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LONIGUTAMAB UGODOTIN
GSRS Full Record:	VJ9X8A8CJ5 i

2363754-30-5
IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL HZ-208F2-4 .GAMMA.1-CHAIN), COMPLEX WITH HUMAN-MUS MUSCULUS MONOCLONAL HZ-208F2-4 .KAPPA.-CHAIN, DIMER, TETRAKIS(THIOETHER) WITH N-(2-(4-((6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)METHYLAMINO)PHENYL)ETHYL)-N-METHYL-L-VALYL-L-VALYL-(3R,4S,5S)-3-METHOXY-5-METHYL-4-(METHYLAMINO)HEPTANOYL-(.ALPHA.R,.BETA.R,2S)-.BETA.-METHOXY-.ALPHA.-METHYL-2-PYRROLIDINEPROPANOYL-L-PHENYLALANINE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IGF1R (INSULIN LIKE GROWTH FACTOR 1 RECEPTOR, IGF1-R, IGF-1R, CD221)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO A DOLASTATIN DERIVATIVE (UGODOTIN GROUPS)
lonigutamab ugodotin [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LONIGUTAMAB UGODOTIN

Synonyms and Mappings

Resources